Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

515 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Comparison of Optical Coherence Tomography Versus Angiography to Guide Bioresorbable Vascular Scaffold Implantation: The OPTICO BVS Study.
Ueki Y, Yamaji K, Barbato E, Nef H, Brugaletta S, Alfonso F, Hill J, Cook S, Burzotta F, Karagiannis A, Windecker S, Räber L. Ueki Y, et al. Among authors: burzotta f. Cardiovasc Revasc Med. 2020 Oct;21(10):1244-1250. doi: 10.1016/j.carrev.2020.03.023. Epub 2020 Mar 19. Cardiovasc Revasc Med. 2020. PMID: 32205067 Clinical Trial.
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study).
Leone AM, Galiuto L, Garramone B, Rutella S, Giannico MB, Brugaletta S, Perfetti M, Liuzzo G, Porto I, Burzotta F, Niccoli G, Biasucci LM, Leone G, Rebuzzi AG, Crea F. Leone AM, et al. Among authors: burzotta f. Am J Cardiol. 2007 Aug 1;100(3):397-403. doi: 10.1016/j.amjcard.2007.03.036. Epub 2007 Jun 8. Am J Cardiol. 2007. PMID: 17659916 Clinical Trial.
Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate.
Niccoli G, Conte M, Della Bona R, Altamura L, Siviglia M, Dato I, Ferrante G, Leone AM, Porto I, Burzotta F, Brugaletta S, Biasucci LM, Crea F. Niccoli G, et al. Among authors: burzotta f. Atherosclerosis. 2008 Jun;198(2):373-80. doi: 10.1016/j.atherosclerosis.2007.09.022. Epub 2007 Nov 5. Atherosclerosis. 2008. PMID: 17983622
Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry.
Burzotta F, Trani C, Todaro D, Mazzari MA, Porto I, De Vita M, Brugaletta S, Coroleu SF, Niccoli G, Leone AM, Giammarinaro M, Mongiardo R, Schiavoni G, Crea F. Burzotta F, et al. Catheter Cardiovasc Interv. 2009 Mar 1;73(4):457-65. doi: 10.1002/ccd.21882. Catheter Cardiovasc Interv. 2009. PMID: 19229977
Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach.
Burzotta F, Trani C, Todaro D, Mariani L, Talarico GP, Tommasino A, Giammarinaro M, Niccoli G, Porto I, Leone AM, Mongiardo R, Mazzari MA, Schiavoni G, Crea F. Burzotta F, et al. JACC Cardiovasc Interv. 2011 Mar;4(3):327-35. doi: 10.1016/j.jcin.2010.12.005. JACC Cardiovasc Interv. 2011. PMID: 21435612 Free article. Clinical Trial.
515 results